The Cancer Prevention & Research Institute of Texas is adding rare cancers and childhood cancers to its list of funding priorities, according to a draft program report.
With major leadership changes, grant disruptions and terminations, and a stoked distrust in science, Steven Artandi, the director of Stanford Cancer Center, worries that young investigators will feel disenchanted by the U.S. research atmosphere and take their work and study elsewhere.
